Medpace Holdings Raises FY2026 GAAP EPS Guidance from $16.68-$17.50 to $17.25-$17.95 vs $16.97 Est; Raises FY2026 Sales Guidance from $2.755B-$2.855B to $2.805B-$2.885B vs $2.778B Est

Loading news article.

Medpace Holdings Raises FY2026 GAAP EPS Guidance from $16.68-$17.50 to $17.25-$17.95 vs $16.97 Est; Raises FY2026 Sales Guidance from $2.755B-$2.855B to $2.805B-$2.885B vs $2.778B Est | WAPE

Medpace Holdings Raises FY2026 GAAP EPS Guidance from $16.68-$17.50 to $17.25-$17.95 vs $16.97 Est; Raises FY2026 Sales Guidance from $2.755B-$2.855B to $2.805B-$2.885B vs $2.778B Est

Article summary

Related companies

Comments —